Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Piper wichmannii
Une plante sauvage apparentée au kava de Papouasie-Nouvelle-Guinée utilisée dans des cérémonies traditionnelles et comme sédatif.
Awa Papua (Piper wichmannii) is a wild kava relative from Papua New Guinea traditionally used in ceremonial contexts and as a sedative. Its primary active compounds include kavalactones such as dihydrokavain and methysticin, which contribute to its anxiolytic and sedative properties. Evidence is limited to preliminary studies and traditional use, indicating potential benefits for anxiety and sleep support.
Kavalactones, particularly dihydrokavain and methysticin, modulate GABA-A receptors, enhancing inhibitory neurotransmission and producing anxiolytic and sedative effects. They also inhibit voltage-gated sodium and calcium channels, reducing neuronal excitability. Additionally, kavalactones may influence monoamine oxidase (MAO) activity and interact with cannabinoid receptors, though these pathways are less characterized. Hepatotoxicity is thought to involve inhibition of cytochrome P450 enzymes and depletion of glutathione, leading to oxidative stress in susceptible individuals.
Une plante sauvage apparentée au kava de Papouasie-Nouvelle-Guinée utilisée dans des cérémonies traditionnelles et comme sédatif.
Awa Papua (Piper wichmannii) is a wild kava relative from Papua New Guinea traditionally used in ceremonial contexts and as a sedative. Its primary active compounds include kavalactones such as dihydrokavain and methysticin, which contribute to its anxiolytic and sedative properties. Evidence is limited to preliminary studies and traditional use, indicating potential benefits for anxiety and sleep support.
Kavalactones, particularly dihydrokavain and methysticin, modulate GABA-A receptors, enhancing inhibitory neurotransmission and producing anxiolytic and sedative effects. They also inhibit voltage-gated sodium and calcium channels, reducing neuronal excitability. Additionally, kavalactones may influence monoamine oxidase (MAO) activity and interact with cannabinoid receptors, though these pathways are less characterized. Hepatotoxicity is thought to involve inhibition of cytochrome P450 enzymes and depletion of glutathione, leading to oxidative stress in susceptible individuals.